SoftOx Solutions AS is pleased to invite investors, analysts and other stakeholders to our Strategy and Capital Markets Day, including Q3 2021 results on Wednesday the 17th ofNovember 2021 at 09.00 to 12.00 (CET). Schedule: 09.00-09.10 Opening with CEOGeir Almås 09.10-10.00 Technology platform and business strategy 10.00-11.30 Program areas for development 11.30-11.45 Finance 11.45-12.00 Q&A The event will be held in-person at Technopolis, Martin Linges Vei 25, 1364 Fornebu,Norway . It will also be streamed live. Please register for the event, before 15th ofNovember 2021 , by sending an email to ir@soft-ox.com The Q3 2021 results will be released at 07:00 (CET) onWednesday November 17, 2021 . The interim report and related materials will be made available on: https://soft-ox.com/financial-calendar-reports/. For further information, please contact: CEOGeir Almås ofSoftOx Solutions AS , or CFO Kristine Mundal Rød ofSoftOx Solutions AS Mail: ir@soft-ox.com Mobile: (+47) 948 59 599 AboutSoftOx Solutions AS SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a Norwegian BioTech company based inOslo with the aim of helping to combat major threats to human health, namely the emergence of antimicrobial resistance (AMR), biofilm infections in chronic wounds and the spread of viruses. For more information on SoftOx, visit www.soft-ox.com
Click here for more information
© Oslo Bors ASA, source